Ginkor Fort R

Related by string. * : Ginkor Fort ® / fort . forts . Forts . FORTS . Forter . FORT : Fort Worth Star Telegram . Fort Mill . FORT WAYNE Ind. . FORT WORTH Texas . Fort Hood Texas . Fort Hood shooter . Fort Drum NY . Cape Coral Fort Myers . FORT COLLINS Colo. / Rs . red . Rd . R. . ring . Ring . RS . RD : MS RD . Rs #.# [005] . Bill Frist R Tenn . R Ind . RED FLAG WARNING WHICH . Toys R Us . Ford Focus RS . Mike Huckabee R-Ark. * *

Related by context. Frequent words. (Click for all words.) 59 Loramyc ® 55 Pierre Fabre 54 Dysport ® 52 UCB SA 51 Testim 51 STADA 50 Toctino ® 50 CHF#.# [002] 50 Helsinn 49 Rhucin 49 Flutiform 49 Movetis 49 Stallergenes 49 Menarini 48 QLT USA 47 Innogenetics 47 Galenica 47 BioAlliance Pharma 47 Cegedim 47 Pirelli RE 47 Organon BioSciences 47 PEG INTRON 47 Betapharm 47 Novexel 46 Servier 46 Meda AB 46 EUR#.#bn [002] 46 Santhera 46 ridaforolimus 46 DNage 46 BioDelivery Sciences 46 Factive 46 Sanofi Aventis 46 Sciele Pharma 46 Sanofi Synthelabo 45 divestments 45 #/#/EC [002] 45 Suedzucker 45 BioAlliance 45 ratiopharm 45 Photocure 45 Merck Serono division 45 € #.#bn [007] 45 orphan designation 45 Merck Serono 45 Galderma 45 Solvay Pharmaceuticals 45 Kyowa Hakko 44 EUR#mn [001] 44 EUR#.# [006] 44 CHF#.# billion [001] 44 Bayer HealthCare AG 44 Solvay SA 44 Debio 44 Durect 44 Nycomed 44 Marketing Authorization 44 PharmaMar 44 Aridol 44 Debiopharm 44 Jerini 44 Orexo 44 GBP#.#m [002] 44 CNP Assurances 44 TopoTarget 44 DRAXIS 44 SkyePharma 44 Swedish Orphan Biovitrum 43 Increlex 43 EUR#.#bn [001] 43 MediGene AG 43 ProStrakan 43 Grunenthal 43 E#.#m [001] 43 Evotec AG 43 Novartis 43 Bentley Pharmaceuticals 43 UCB Pharma 43 Basilea 42 € #.#bn [001] 42 Octapharma 42 Debiopharm Group 42 orphan medicinal product 42 PAION 42 EUR#.#bn [005] 42 € #.#bn [005] 42 Directive #/#/EC [004] 42 Janssen Pharmaceutical 42 Ipsen 42 NicOx 42 EUR #.#mn [002] 42 Janssen Cilag 42 Transgene 42 Abbott Molecular 42 Eurand 42 IDM Pharma 42 SFr#.# billion [003] 42 & s2 = 42 Currency fluctuations 42 GSK 41 Sanofi aventis

Back to home page